Skip to Main Content
A newly developed surface analysis technique, which combines secondary ion mass spectrometry with angle-resolved X-ray photoelectron spectroscopy, was used to achieve more accurate results of the retained impurity doses and profiles for ultralow-energy implants, including conventional beamline implant and plasma immersion ion implantation (PIII). Using this method, it has been found that the B2H6 (diborane) PIII demonstrates thicker native oxide and much more B dose loss during rapid thermal processing and surface-cleaning treatments than conventional beamline ion implantation, due to the higher surface B concentration. In order to match the electrical parameters of the device, PIII must consider higher nominal dose to compensate the B loss.
Date of Publication: Jan. 2009